Home > Boards > Free Zone > Health and Sciences > Biotech Values

NKTR—I may be beating a dead horse, but

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 752
Posts 116,068
Boards Moderated 12
Alias Born 09/05/02
160x600 placeholder
Nigerian President Travels to U.K. for Medical Follow-Up
By Obafemi Oredein
Hogs Futures Fall as U.S. Inventories Rise
Wheat Declines as Weather Turns Wetter
Front Month Nymex RBOB Gasoline Rose 0.62% to Settle at $2.2809 -- Data Talk
Front Month Nymex Natural Gas Rose 2.55% to Settle at $3.4180 -- Data Talk
Snapchat Users Gain Access to Universal Music Group's Library of Music
4D Molecular Shares Hit 52-Week Low After Roche Ends Collaboration Agreement
Pieris Pharmaceuticals Shares Rise 19% After Getting Orphan Drug Status
Top Company News of the Day
CAC-40 Index Ends 1.22% Higher at 6631.15 -- Data Talk
FTSE 100 Index Ends 0.51% Higher at 7109.97 -- Data Talk
STOXX Europe 50 Index Ends 0.67% Higher at 3542.88 -- Data Talk
DAX Ends 0.86% Higher at 15589.23 -- Data Talk
EURO STOXX 50 Index Ends 1.14% Higher at 4122.43 -- Data Talk
STOXX Europe 600 Index Ends 0.87% Higher at 457.04 -- Data Talk
FTSE 100 Closes Higher as Bank of England Keeps Bank Rate Unchanged
Biogen Worst Performer in S&P 500 and Nasdaq 100 So Far Today -- Data Talk
Manufacturing Activity in Central U.S. Expands Strongly in June -- Kansas City Fed
Merck Names Michael Klobuchar Chief Strategy Officer
Personal Income Seen Down 2.7% in May -- Data Week Ahead
Mortgage Rates Climb Above 3%, Freddie Mac Says
Gilead Sciences Sees Positive Results From Trial for Hepatitis Treatment
Prothena to Get $80 Million After Bristol Myers Exercises Option for Alzheimer's Treatment
Belgium Business Confidence Reaches All-Time High in June
4D Molecular Therapeutics Gets Termination Notice From Roche
FTSE 100 Builds on Gains After Bank of England Decision
AgEagle Aerial Systems Expands Licensing Deal With Florida Agriculture Department
Soybean Export Sales Stay Low
DewDiligence Member Level  Monday, 11/11/19 10:58:01 AM
Re: dewophile post# 226781
Post # of 238492 
NKTR—I may be beating a dead horse, but “holding serve” in tennis—thereby avoiding a very bad outcome—is not neutral, but rather is modestly bullish, even against a weak opponent.

Your HCV analogy does not directly apply to the NKTR situation, IMO, insofar as SVR12 in HCV has been empirically shown to be tantamount to a full-fledged cure. (Using your tennis analogy, extending SVR12 to SVR24 is not equivalent to holding serve, since the match was effectively over when SVR12 was reached.) We cannot (yet) make the same assertion about an I-O regimen in melanoma that elicits a CR at 12 weeks.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences